HDAC inhibition in cancer therapy: an increasingly intriguing tale of chemistry, biology and clinical benefit
Tools
Ten Holte, P., Van Emelen, K., Janicot, M., Fong, P. C., de Bono, J. S., Arts, J.
(2007)
HDAC inhibition in cancer therapy: an increasingly intriguing tale of chemistry, biology and clinical benefit.
In:
Cancer.
Topics in Medicinal Chemistry, 1
.
Springer Verlag, Berlin, Germany, pp. 293-332.
ISBN 978-354033119-3
Full text not available from this repository.
Item Type: | Book Section |
---|---|
Authors (ICR Faculty only): | Debono, Johann |
All Authors: | Ten Holte, P., Van Emelen, K., Janicot, M., Fong, P. C., de Bono, J. S., Arts, J. |
Editors: | Bradbury, R. H. |
Research teams: | ICR divisions > Cancer Therapeutics > Cancer Biomarkers ICR divisions > Clinical Studies > Cancer Biomarkers ICR divisions > Clinical Studies > Prostate Cancer Targeted Therapy Group |
Depositing User: | Users 10 not found. |
Date Deposited: | 28 Aug 2008 16:12 |
Last Modified: | 11 Jul 2017 14:10 |
URI: | http://publications.icr.ac.uk/id/eprint/6857 |
Actions (login required)
![]() |
View Item |